Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 1
2005 1
2006 2
2007 4
2008 2
2009 1
2010 4
2011 2
2012 4
2013 1
2014 5
2015 9
2016 10
2017 5
2018 6
2019 3
2020 13
2021 19
2022 11
2023 8
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas.
Perrone E, Ghai K, Eismant A, Andreassen M, Langer SW, Knigge U, Kjaer A, Baum RP. Perrone E, et al. Among authors: langer sw. Diagnostics (Basel). 2024 Apr 26;14(9):907. doi: 10.3390/diagnostics14090907. Diagnostics (Basel). 2024. PMID: 38732321 Free PMC article.
Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000-2020.
Petersen SS, Møller S, Slott C, Krogh J, Hansen CP, Kjaer A, Holmager P, Oturai P, Garbyal RS, Langer SW, Knigge U, Andreassen M. Petersen SS, et al. Among authors: langer sw. Cancers (Basel). 2024 Mar 18;16(6):1190. doi: 10.3390/cancers16061190. Cancers (Basel). 2024. PMID: 38539524 Free PMC article.
Appendiceal Neuroendocrine Neoplasms: an Update for 2023.
Holmager P, Langer SW, Kjaer A, Ringholm L, Garbyal RS, Hansen CP, Andreassen M, Knigge U. Holmager P, et al. Among authors: langer sw. Curr Oncol Rep. 2024 Feb;26(2):114-120. doi: 10.1007/s11912-023-01484-4. Epub 2024 Jan 2. Curr Oncol Rep. 2024. PMID: 38168835 Review.
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Mau-Sørensen M, Gerner-Rasmussen J, Hansen O, Holm B, Nyhus CH, McCulloch T, Nielsen HA, Wedervang K, Rytter C, Jeppesen N, Langer SW. Mau-Sørensen M, et al. Among authors: langer sw. Acta Oncol. 2023 Dec;62(12):1979-1982. doi: 10.1080/0284186X.2023.2278173. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37934081 Clinical Trial. No abstract available.
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
Morken S, Langer SW, Sundlöv A, Vestermark LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud TM, Assmus J, Detlefsen S, Couvelard A, Perren A, Sorbye H. Morken S, et al. Among authors: langer sw. Br J Cancer. 2023 Dec;129(12):1930-1939. doi: 10.1038/s41416-023-02462-0. Epub 2023 Oct 23. Br J Cancer. 2023. PMID: 37872405 Free PMC article. Clinical Trial.
107 results